CSS LLC’s Trillium Therapeutics Inc. TRIL Stock Holding History

CSS LLC’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-116,154	Closed	-$2.04M	–	1536
2021 Q3	$2.04M	Buy	116,154 +53,901	+87%	+$630K	0.09%	241
2021 Q2	$604K	Sell	62,253 -29,055	-32%	-$273K	0.03%	548
2021 Q1	$981K	Sell	91,308 -17,116	-16%	-$212K	0.04%	396
2020 Q4	$1.59M	Buy	108,424 +64,039	+144%	+$923K	0.06%	234
2020 Q3	$631K	Buy	+44,385	New	+$443K	0.03%	376
2020 Q2	–	Sell	-6,169	Closed	-$38.2K	–	787
2020 Q1	$25K	Buy	+6,169	New	+$23.3K	﹤0.01%	557

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

CSS LLC's TRIL Position: Q4 2021 in Review

CSS LLC sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 116,154 shares — an estimated $2.04M sold.

CSS LLC first reported a position in TRIL in Q1 2020 and held it in 6 quarters. The position peaked at $2.04M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

CSS LLC reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
CSS LLC sold 116,154 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2.04M.
CSS LLC first reported a position in Trillium Therapeutics Inc. in Q1 2020 and held it in 6 quarters.
CSS LLC's Trillium Therapeutics Inc. position peaked at $2.04M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on CSS LLC's 13F filing for Q4 2021, filed 14 Feb 2022.